Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 07, 2026
A new clue to resistance in metastatic prostate cancer
From Dr. Steven Blinka, Clinical Research Division and the Hsieh Lab, Human Biology Division
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
A Nature study reveals that a single transfer RNA (tRNA) helps determine whether prostate cancer remains treatment-sensitive or becomes resistant, opening new avenues in precision oncology
Fred Hutch researchers discover molecular switch that helps prostate cancer quickly change its biology to evade therapy
Drs. Andrew Hsieh and Rashmi Mishra identify a key step in the protein-making process that turns a treatable form of prostate cancer into a more lethal, drug-resistant subtype — and a way to switch it back
Sidelining cancer treatment’s side effects through exercise, nutrition, prehab and rehab
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer survivor and the medical director of Fred Hutch’s cancer rehab about treatment’s aftermath
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better